Company intelligence / Profile preview

Regenes

Ownership: Private
Development stage: Other

Overview

Regene is a precision health biotech company specializing in consumer DNA testing and genomic analysis. It offers direct-to-consumer tests that analyze hundreds of thousands of genetic markers using microarray technology and polygenic risk scoring to provide personalized health insights. The company also provides whole exome sequencing for more comprehensive disease risk assessment, supporting both individual wellness optimization and family planning[1].

Therapeutic areas: Women's HealthOther
Modalities: DNA testingGenomic analysis
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Regenes.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regenes.

Explore the full profile